ECL Form 4: Director Exercises Options and Sells Shares at ~$283
Rhea-AI Filing Summary
Ecolab director Suzanne M. Vautrinot reported option exercise, share sale and share withholding transactions. On 08/14/2025 she exercised a non-employee stock option to acquire 2,300 shares at an exercise price of $115.075 per share; the option had a first vesting date of 08/05/2016 and expires 05/05/2026. The exercise was satisfied by delivering or withholding shares per Rule 16b-3, reflected as a disposition of 946 shares at $279.65. On 08/19/2025 she sold 1,354 shares at a weighted average price of $283.162, reducing her direct beneficial ownership to 11,199.2 shares. The Form 4 is signed by an attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine option exercise with partial share withholding and a subsequent sale; no material change to control.
The filing documents a standard exercise of a previously granted non-employee stock option and routine post-exercise share management. The director exercised 2,300 option shares at $115.075 while immediately surrendering/withholding 946 shares to cover the exercise price and taxes, then sold 1,354 shares at a weighted average of $283.162. Following these transactions the reporting person holds 11,199.2 shares directly. These transactions are typical for option exercises and do not indicate a change in corporate control or a large shift in insider ownership percentage.
TL;DR: Transactions comply with Rule 16 reporting and Rule 16b-3 mechanics; disclosure appears complete and timely.
The Form 4 lists exercise, share withholding and an open-market sale consistent with Rule 16b-3 practices for satisfying option exercise obligations. The filing includes the exercise price, sale prices (weighted average disclosed for the sale), vesting and expiration dates, and an explanation that shares were delivered or withheld to pay the exercise price. The form is executed by an attorney-in-fact, with signature dated 08/19/2025, satisfying Form 4 execution requirements. No enforcement, governance or noncompliance issues are evident from the disclosed transactions alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,354 | $283.162 | $383K |
| Exercise | Non-Employee Stock Option (Right to Buy) | 2,300 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,300 | $115.075 | $265K |
| Exercise Price or Tax Liability | Common Stock | 946 | $279.65 | $265K |
Footnotes (3)
- F1. Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock.
- F2. This transaction was executed in multiple trades at prices ranging from $283.146 to $283.165, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date.
FAQ
What transactions did Suzanne M. Vautrinot report on the Form 4 for ECL?
When does the exercised option expire and when was it first exercisable?
Who signed the Form 4 and when was it filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.